The Complete Guide to Egg Donation When You Have Herpes: Risks, Precautions, and Legal Insights

Herpes simplex virus (HSV) lives in nerve cells and can reactivate sporadically, producing cold sores or genital lesions. During an egg donation cycle, the primary concern is whether the virus can travel to the ovaries or be present in the follicular fluid that will eventually become an embryo. Research shows that HSV DNA is rarely detectable in reproductive tissues when the donor is asymptomatic, meaning the virus does not typically compromise the intrinsic quality of the oocyte itself.

However, the presence of an active outbreak—visible sores or prodromal tingling—creates a window where viral shedding spikes. Clinics therefore schedule the stimulation phase during a symptom‑free period and may prescribe antivirals like valacyclovir to suppress reactivation. This approach protects both the donor’s health and the downstream embryo development process.

Before any donor steps into a clinic, a comprehensive medical history is taken, including a detailed HSV assessment. Blood tests for HSV‑1 and HSV‑2 antibodies confirm exposure, while a physical exam checks for active lesions. If you have a history of frequent outbreaks, the clinic might request a longer observation period to ensure you can maintain a stable, lesion‑free window for the stimulation cycle.

During the screening, the fertility team also evaluates your ovarian reserve, hormone levels, and overall reproductive health. The goal is to separate the viral factor from other variables that could affect egg yield. In practice, a donor with herpes who passes these hurdles proceeds much like any other donor—except with an added layer of timing and medication management.

The scientific consensus is reassuring: herpes does not degrade the genetic material inside an egg. Oocytes are formed during fetal development and remain largely unchanged until ovulation. HSV does not infiltrate the egg’s nucleus or cytoplasm under normal circumstances. What can be affected, however, is the donor’s response to ovarian stimulation drugs. Some women report heightened discomfort or mild inflammation during a flare, which can slightly alter hormone absorption.

Clinics mitigate this by adjusting medication dosages or selecting protocols that are gentler on the immune system. For example, a mild antagonist protocol may be chosen over a more aggressive agonist regimen if the donor’s immune response is a concern. The net effect is that most donors with well‑controlled herpes produce eggs comparable in quality and number to those without the virus.

Timing is everything. Once you receive the start date for your stimulation, you’ll begin a short course of antiviral medication—typically 500 mg of valacyclovir twice daily—starting three days before hormone injections. This pre‑emptive strategy keeps viral replication at bay during the critical window when follicles are maturing.

In addition to medication, strict hygiene practices are non‑negotiable. Avoid touching lesions, wash hands thoroughly before any clinic visit, and wear gloves during any procedures that involve direct contact with genital tissue. Some clinics also recommend abstaining from sexual activity for 48 hours before egg retrieval to eliminate any risk of mechanical transfer of viral particles.

Transparency balances with privacy. Legally, the donor’s medical history—including HSV status—must be disclosed to the intended recipient or their agency, but the information is often anonymized. The recipient receives a summary that notes “herpes simplex virus type 1/2, asymptomatic at time of donation,” without revealing your identity.

Confidentiality clauses in the donor agreement protect your personal details, but they do not erase the medical facts. This arrangement satisfies ethical guidelines while preserving donor anonymity. If a recipient has specific concerns, the clinic mediates a conversation, ensuring both parties understand the risk profile and the safeguards in place.

Egg donation contracts are dense documents that spell out disclosure requirements, liability limits, and compensation adjustments. For donors with herpes, the contract will typically include a clause stating that you have informed the clinic of your HSV status and that you will adhere to the antiviral regimen prescribed.

Should a transmission event occur—a scenario that is exceedingly rare—the contract outlines the legal recourse for the recipient, often limiting the donor’s liability to the extent of negligence. In practice, because clinics enforce strict protocols, the risk of legal fallout is minimal, but being aware of these clauses helps you negotiate fair compensation and understand your rights.

Not all drugs play nicely with antiviral therapy. Non‑steroidal anti‑inflammatory drugs (NSAIDs) can sometimes trigger HSV reactivation by altering immune pathways, so many clinics advise limiting ibuprofen or naproxen during the stimulation phase. Instead, acetaminophen is preferred for mild pain.

On the flip side, certain supplements—like lysine—have anecdotal support for reducing outbreak frequency, though evidence is mixed. Your reproductive endocrinologist can help you craft a medication plan that avoids immune‑suppressing agents, incorporates antivirals, and respects any personal health conditions you may have.

Success hinges on communication. Keep your clinic updated about any prodromal symptoms, even if they seem minor. Early reporting allows the team to pause the cycle, adjust antivirals, or reschedule retrieval without compromising egg quality.

Post‑retrieval, the eggs are washed and cryopreserved, a process that removes any surface contaminants, including viral particles. This extra layer of safety means the embryos created from your eggs are virtually free of HSV. By following the clinic’s timeline, adhering to medication, and maintaining open dialogue, you set the stage for a smooth donation that protects everyone involved.

Beyond the immediate cycle, think about the broader picture. Some agencies keep donor records for years, tracking any health updates that could affect future offspring. If you develop a new health condition or experience a change in outbreak frequency, you’re obligated to inform the agency so they can update the recipient’s file if the eggs are still in use.

Additionally, consider the psychological aspect. Knowing you’ve contributed to a family’s journey can be rewarding, but it also means staying informed about any emerging research on HSV and reproductive health. Staying engaged with your fertility clinic’s newsletters or support groups can keep you ahead of any policy shifts that might affect your donor status.